2017
DOI: 10.1007/s10895-017-2177-0
|View full text |Cite
|
Sign up to set email alerts
|

Anticancer Activity of Copper Complex of (4R)-(-)-2-Thioxo-4-thiazolidinecarboxylic Acid and 3-Rhodaninepropionic Acid on Prostate and Breast Cancer Cells by Fluorescent Microscopic Imaging

Abstract: Copper complexes with strong anticancer activity are promising new drugs for treatment of patients with metastatic cancer. Copper 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide (CuHQTS) and copper 8-hydroxyquinoline-2-carboxaldehyde-4,4-dimethyl-3-thiosemicarbazide (CuHQDMTS) were found to have strong anticancer activity against cisplatin-resistant neuroblastoma cells and prostate cancer cells. This study aimed to synthesize and characterize two new anticancer copper complexes, copper complex of (4R)-(-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 20 publications
0
6
0
Order By: Relevance
“…Additionally, two copper thiosemicarbazone complexes showed similar effect on cisplatin-resistant neuroblastoma cells and prostate cancer. Xie et al [46] reported the synthesis and antitumoral activity of two copper complexes of (4R)-2-thioxo-4-thiazolidinecarboxylic acid (TTDC) and 3-rhodaninepropionic acid (RDPA) against prostate cancer, presenting both of them variable potency, likely related to different functional groups on TTDC and RDPA ligands. Owing to the presence of sulfur and amino groups in CuTTDC and CuRDPA, these complexes had emerged as ligands to attach to delivery vehicles, such as peptides or monoclonal antibodies for targeted delivery.…”
Section: Thiazole and Metal Complexesmentioning
confidence: 99%
“…Additionally, two copper thiosemicarbazone complexes showed similar effect on cisplatin-resistant neuroblastoma cells and prostate cancer. Xie et al [46] reported the synthesis and antitumoral activity of two copper complexes of (4R)-2-thioxo-4-thiazolidinecarboxylic acid (TTDC) and 3-rhodaninepropionic acid (RDPA) against prostate cancer, presenting both of them variable potency, likely related to different functional groups on TTDC and RDPA ligands. Owing to the presence of sulfur and amino groups in CuTTDC and CuRDPA, these complexes had emerged as ligands to attach to delivery vehicles, such as peptides or monoclonal antibodies for targeted delivery.…”
Section: Thiazole and Metal Complexesmentioning
confidence: 99%
“…Thiosemicarbazide groups are functional groups whose derivatives display pharmacological properties that may be further enhanced by incorporation of metal ions (Salah et al, 2018). Thus, both free thiosemicarbazides and their metal complexes have been investigated as anticancer (Güniz Küçükgüzel and Coşkun, 2016; Xie and Peng, 2018; Xie et al, 2018), antiviral (Cihan-Üstündag et al, 2016), and antibacterial (Brahma et al, 2018; Molnar et al, 2018) agents.…”
Section: Introductionmentioning
confidence: 99%
“…Cysteine has an SH group and can react with the vinyl and aldehyde groups through Michael and nucleo­philic additions to form mono- and dicysteine–acrolein adducts. The latter is easily dehydrated to form thiazolidine–carboxylic acid, exhibiting possible antitumor activity …”
Section: Acroleinmentioning
confidence: 99%